CompletedNCT02422186
What is this study about?This study evaluated the safety and effectiveness of Esketamine for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including San DiegoDepressionMedication studyAges 65+
- Countries
- United States, France, United Kingdom, + 9 others
- Sponsor
- Janssen Research & Development, LLC
UnknownNCT06323486
Official study titleEffects of Accelerated Bilateral Sequential Theta Burst Stimulation on Dual-task Cost, Depression, Cognition and Other Outcomes in Older Adults With Treatment-resistant Depression: A Randomized, Double-blind, Sham-controlled Trial
Current recruitment status is unconfirmed.
In TorontoDepressionDevice studyAges 50+
- Countries
- Canada
- Sponsor
- Ontario Shores Centre for Mental Health Sciences
CompletedNCT03109002
Official study titleEpidemiology of Treatment Resistant Depression in the US: Analysis of Health Services Databases
This study has finished and is no longer accepting participants.
Location not clearly listedDepressionObservational studyAges 14+
- Countries
- Sponsor
- Janssen Research & Development, LLC
CompletedNCT07099235
Official study titleRetrospective Chart Review of Patients Undergoing Intravenous Ketamine Treatments for Treatment-resistant Depression
This study has finished and is no longer accepting participants.
In MississaugaDepressionObservational studyAges 18+
- Countries
- Canada
- Sponsor
- Sunnybrook Health Sciences Centre
CompletedNCT01983904
Official study titleTherapeutic Brain Stimulation for Refractory Depression
This study has finished and is no longer accepting participants.
In CalgaryDepressionDevice studyAges 20–70
- Countries
- Canada
- Sponsor
- University of Calgary
Active Not RecruitingNCT01798407
Official study titleA Clinical Pilot Study Examining Bilateral Inhibition of the Lateral Habenula as a Target for Deep Brain Stimulation in Intractable Depression
This study is no longer accepting new participants.
In HoustonDepressionDevice studyAges 21–70
- Countries
- United States
- Sponsor
- Wayne Goodman MD
CompletedNCT00367003
This study has finished and is no longer accepting participants.
In AtlantaDepressionDevice studyAges 18–70
- Countries
- United States
- Sponsor
- Emory University
CompletedNCT01973478
Official study titleDeep Brain Stimulation in Patients With Chronic Treatment Resistant Depression
This study has finished and is no longer accepting participants.
Multiple locations, including MarseilleDepression, BipolarityDevice studyAges 18–70
- Countries
- France
- Sponsor
- Rennes University Hospital
Enrolling By InvitationNCT07569133
Official study titleEfficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's Disease : A Single-Center, Randomized, Double-Blinded, Sham-Controlled, Parallel-Design, Investigator-Initiated Exploratory Clinical Trial
This study is by invitation only.
In DaeguDepressionDevice studyAges 40–90
- Countries
- South Korea
- Sponsor
- Ho-Won Lee
CompletedNCT05930509
This study has finished and is no longer accepting participants.
In BarcelonaDepressionDevice studyAges 18+
- Countries
- Spain
- Sponsor
- Institut Guttmann
CompletedNCT05194267
Official study titleIntensive Transcranial Direct Current Stimulation in the Treatment of Major Depression: Feasibility Study
This study has finished and is no longer accepting participants.
In MontrealDepressionDevice studyAges 18–65
- Countries
- Canada
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
CompletedNCT03887624
What is this study about?This study evaluated the safety and effectiveness of Ethosuximide for people with depression.
This study has finished and is no longer accepting participants.
In HangzhouDepressionMedication studyAges 18–65
- Countries
- China
- Sponsor
- Zhejiang University